Digital Pathology: Technologies and Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	191 Pages	BCC Research	November, 2022	WA17493039

Best Price Guarantee
Price	from $5,500
Length	191 Pages
Publisher	BCC Research
Published Date	November, 2022
SKU	WA17493039

Digital Pathology: Technologies and Global Markets

Report Scope:

This report includes forecasted trends and sales in the digital pathology markets through 2027. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends, and competitive scenarios that will form the base data for qualitative analysis and market estimates.

The digital pathology and telepathology market have been analyzed for the four main geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and information generated from pathology labs and that regarding specific diagnosis; but it will exclude general hospital-based mHealth issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.
Report Includes:
52 data tables and 32 additional tables

An up-to-date overview and analysis of the global markets for digital pathology technologies

Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the upcoming market opportunities for the digital pathology market, industry specific growth driving factors, and areas of focus to forecast this market into various segments and sub-segments

Estimation of the actual market size and market forecast for digital pathology in value (USD millions) terms, and their corresponding market share analysis by system, type, application, end-user, and geographic region

In-depth information (facts and figures) concerning major market dynamics, technology updates, new products and applications, and COVID-19 impact on the market for digital pathology

Coverage of the technological, economic, and business considerations of the global market for digital pathology, with analyses and market forecasts through 2027

Updated information on key mergers and acquisition deals, agreements, collaborations and product launches within the digital pathology industry

A relevant patent analysis

Analysis of the company competitive landscape for digital pathology market, and company value share analysis based on segmental revenues and key financial performance

Profile descriptions of the leading global companies, including CliniSys, F. Hoffmann-La Roche Ltd., Leica Biosystems Inc., Nikon Instruments Inc., and XIFIN Inc.

Companies Mentioned

3dhistech Ltd.
Apollo Enterprise Imaging Corp.
Clinisys
Corista
F. Hoffmann-la Roche Ltd.
Huron Technologies International Inc.
Indica Labs Inc.
Inspirata Inc.
Leica Biosystems Inc.
Ligolab Information Systems Llc
Mikroscan Technologies Inc.
Nikon Instruments Inc.
Visiopharm
Xifin

Chapter 1 Introduction: 1.1 Study Goals and Objectives; 1.2 Study Background; 1.3 Scope of Report; 1.4 Intended Audience; 1.5 Information Source and Methodology; 1.6 What's New in This Update?; 1.7 Analyst's Credentials; 1.8 BCC Custom Research; 1.9 Related BCC Research Reports
Chapter 2 Executive Summary
Chapter 3 Market Overview: 3.1 Current Trends in Digital Pathology; 3.1.1 Collaborations to Develop Better Solutions; 3.1.2 Innovations to Surge Market Growth; 3.1.3 Cloud Computing to Enhance Healthcare Delivery Systems; 3.1.4 Digital and Computational Pathology; 3.2 Telepathology and Digital Pathology Market Definition, Evolution and Integration; 3.2.1 Key Markets for Digital Telepathology; 3.3 Conventional Process Versus Digital Pathology and Cost Works; 3.4 Image Analysis and Its Importance in Key Research Areas; 3.5 Digital Pathology in Clinical Trials; 3.6 Digital Pathology: Electronic Health Records, Electronic Medical Records and Other Information Systems; 3.7 Regulatory Environment; 3.7.1 United States; 3.7.2 United Kingdom; 3.8 Technology Trends; 3.8.1 Scanning Speeds and Image Resolutions; 3.8.2 Viewing Advancements and Clinical Decision Support; 3.8.3 Archival Standards; 3.8.4 Multi-Site Collaboration Applications; 3.8.5 Whole-Slide Digital Imaging; 3.8.6 Cloud Computing and Digital Pathology; 3.8.7 Laboratory Information Systems; 3.9 Digital Pathology: Developed Versus Developing Economies; 3.10 The Middle East and African Digital Pathology Market Trends; 3.11 Market Intelligence; 3.12 Technology Transition: Digital Pathology Components to Integrated Systems; 3.13 Digital Market Segment Overview; 3.13.1 Whole-Slide Imaging; 3.13.2 Laboratory Information Management System; 3.13.3 Medical Imaging Informatics; 3.14 Agreements and Collaborations to Enhance Presence in Imaging Applications; 3.15 U.S. as the Base for Digital Pathology System Innovation; 3.16 Strategic Conclusions; 3.17 Case Studies; 3.17.1 Case Study 1: Digital Pathology Enabling Critical Diagnosis; 3.17.2 Case Study 2: Initiatives and Examples of Telepathology Deployment in Developing Economies; 3.17.3 Case Study 3: Digital Pathology's Role in Cost Savings Among Big Pharma Companies; 3.17.4 Case Study 4: Digital Pathology in Resource-poor Settings; 3.17.5 Case Study 5: Health Evaluation Centers in Vietnam -- Business Model of Medical Support of Foreign Countries with WSI Telepathology; 3.17.6 Case Study 6: Complete Digital Pathology for Primary Diagnosis, Two Years on: The Experience at Granada 3.17.1 University Hospitals, Spain; 3.17.7 Case Study 7: Telepathology in Mongolia; 3.17.8 Case Study 8: The Prostate Cancer Image Epidemiology Project: Toward Model-based Histopathology, Sweden; 3.17.9 Case Study 9: A Financial Projection for Digital Pathology Implementation at a Large, Integrated Healthcare Organization; 3.18 Market Dynamics; 3.18.1 Drivers; 3.18.2 Restraints; 3.18.3 Challenges and Opportunities; 3.19 Impact of the COVID-19 Pandemic; 3.19.1 Introduction; 3.19.2 Impact on Digital Pathology Market
Chapter 4 Digital Pathology System Market: 4.1 Challenges in Implementing AI; 4.2 Digital Pathology Devices Market; 4.2.1 Virtual Microscopy and Virtual Slides; 4.2.2 Digital Cameras; 4.2.3 Robotic Microscopes; 4.2.4 Image Sensors; 4.2.5 Scanners; 4.3 Digital Pathology Analytics Market; 4.3.1 Visualization and Image Analysis Platforms; 4.3.2 Digital Pathology Information Management Systems; 4.4 Digital Pathology Storage Market; 4.4.1 Vendor-Neutral Archive; 4.5 Communication Platform Market; 4.5.1 Web-based or Cloud-based Communication Platforms in Digital Pathology; 4.5.2 Internet of Medical Things (IoMT) Enabling Real-time Monitoring and Action; 4.5.3 Increased Adoption of Electronic Healthcare Records (EHRs); 4.5.4 Artificial Intelligence (AI) on the Cloud to Facilitate Better Diagnostics; 4.5.5 Telemedicine Bringing Healthcare to Rural and Remote Areas; 4.5.6 Digital Twins Enable Safe Testing Environments; 4.6 Telepathology Systems; 4.6.1 Key Advantages of Telepathology Systems; 4.6.2 Static Image-based Systems; 4.6.3 Hybrid Telepathology Systems; 4.6.4 Real-time Telepathology Imaging Systems
Chapter 5 In Vitro and Other Diagnostic Devices in the Digital Pathology Market: 5.1 Automated Hematology Analyzers and Blood Cell Counters; 5.1.1 Hematology Analyzer Components and Mechanics; 5.1.2 Hematology Instrument Software; 5.1.3 Hematology Instrumentation from the Manufacturer's Perspective; 5.1.4 Advanced Hematology Analyzer Model Market; 5.1.5 Standard Hematology Analyzer Model Market; 5.1.6 Digital Cell Counter Features; 5.1.7 Current Products and Features; 5.2 Digital Chromosome Analyzers; 5.3 Fluorescence In Situ Hybridization Enumeration Systems; 5.4 Digital Urine Sediment Analyzers; 5.5 Immunohistochemistry Image Analysis Applications; 5.6 Digital Cytopathology; 5.7 Digital Polymerase Chain Reaction; 5.7.1 Digital Polymerase Chain Reaction Applications; 5.7.2 Digital Polymerase Chain Reaction Advantages; 5.7.3 Real-Time Versus Traditional Versus Digital Polymerase Chain Reaction; 5.8 Signet Cell Detection; 5.9 Digital Holographic Microscopy
Chapter 6 Digital Pathology Market by Type: 6.1 Anatomical Pathology; 6.1.1 Key Considerations for Integrating Digital Pathology Systems with Anatomy Pathology Laboratory Information Systems; 6.1.2 Genetic Pathology; 6.2 Hematology and Clinical Pathology; 6.3 Immunopathology; 6.4 Chemical Pathology; 6.5 Forensic Pathology; 6.6 Microbiology
Chapter 7 Digital Pathology Market by Application: 7.1 Disease Diagnosis; 7.2 Drug Discovery and Drug Development; 7.2.1 Digital Image Uses; 7.3 Research and Development
Chapter 8 End-User Market: 8.1 Biotech and Pharma Companies; 8.2 Hospitals and Diagnostic Centers; 8.3 Academic Centers and Others
Chapter 9 Regional Market Analysis: 9.1 North America; 9.2 Europe; 9.2.1 Case Study: Implementation Issues for Virtual Microscopy in Europe; 9.3 Asia-Pacific; 9.3.1 China; 9.3.2 India; 9.4 Rest of the World (RoW)
Chapter 10 Competitive Landscape: 10.1 New Product Development; 10.2 Other Key Strategies
Chapter 11 Patent Analysis: 11.1 U.S. Patent Analysis; 11.2 European Patent Analysis; 11.3 Japan Patent Analysis; 11.4 List of Patents
Chapter 12 Company Profiles: 3DHISTECH LTD.; APOLLO ENTERPRISE IMAGING CORP.; CLINISYS; CORISTA; F. HOFFMANN-LA ROCHE LTD.; HURON TECHNOLOGIES INTERNATIONAL INC.; INDICA LABS INC.; INSPIRATA INC.; LEICA BIOSYSTEMS INC.; LIGOLAB INFORMATION SYSTEMS LLC; MIKROSCAN TECHNOLOGIES INC.; NIKON INSTRUMENTS INC.; VISIOPHARM; XIFIN